GeneDx Holdings (WGSWW) Long-Term Deferred Tax (2020 - 2021)

GeneDx Holdings (WGSWW) reported Long-Term Deferred Tax of $426000.0 for Q1 2021, up 954.46% quarter-over-quarter from $40400.0 in Q4 2020.

GeneDx Holdings (WGSWW) Long-Term Deferred Tax (2020 - 2021) Analysis & Trends

GeneDx Holdings (WGSWW) has 2 years of Long-Term Deferred Tax data on file, last reported at $426000.0 in Q1 2021.

Long-Term Deferred Tax for Q1 2021 came in at $426000.0, changed N/A year-over-year; the trailing twelve-month figure through Mar 2021 was $426000.0 (changed N/A YoY), and the FY2020 annual result was $40400.0, changed N/A from the prior year.
Long-Term Deferred Tax advanced to $426000.0 in Q1 2021 per WGSWW's latest filing, from $40400.0 in the prior quarter.
Over five years, Long-Term Deferred Tax peaked at $426000.0 in Q1 2021 and troughed at $12000.0 in Q3 2020.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Waters	29,149.49 Bn	29,149.03 Bn	1.11 Bn
2	Thermo Fisher Scientific	174.37 Bn	171.12 Bn	7.74 Bn
3	Danaher	127.33 Bn	121.64 Bn	3.59 Bn
4	Idexx Laboratories	44.68 Bn	44.48 Bn	722.74 Mn
5	Agilent Technologies	36.54 Bn	34.74 Bn	990.00 Mn
6	Iqvia Holdings	30.51 Bn	28.53 Bn	1.36 Bn
7	Natera	30.00 Bn	28.90 Bn	696.04 Mn
8	Illumina	24.61 Bn	23.45 Bn	721.00 Mn
9	Mettler Toledo International	22.91 Bn	22.85 Bn	555.82 Mn
10	GeneDx Holdings	-	-	68.21 Mn

Download Data